A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

被引：131

作者：

Alsoussi, Wafaa B. ^{[1
]}

Turner, Jackson S. ^{[1
]}

Case, James B. ^{[2
]}

Zhao, Haiyan ^{[1
]}

Schmitz, Aaron J. ^{[1
]}

Zhou, Julian Q. ^{[3
]}

Chen, Rita E. ^{[2
]}

Lei, Tingting ^{[1
]}

Rizk, Amena A. ^{[1
]}

McIntire, Katherine M. ^{[1
]}

Winkler, Emma S. ^{[1
,2
]}

Fox, Julie M. ^{[2
]}

Kafai, Natasha M. ^{[1
,2
]}

Thackray, Larissa B. ^{[2
]}

Hassan, Ahmed O. ^{[2
]}

Amanat, Fatima ^{[4
,5
]}

Krammer, Florian ^{[4
]}

Watson, Corey T. ^{[6
]}

Kleinstein, Steven H. ^{[3
,7
,8
]}

Fremont, Daved H. ^{[1
,9
,10
]}

Diamond, Michael S. ^{[1
,2
,9
,11
,12
]}

Ellebedy, Ali H. ^{[1
,9
,11
,12
]}

机构：

[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA

[2] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA

[3] Yale Univ, Yale Sch Med, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06511 USA

[4] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10024 USA

[5] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10024 USA

[6] Univ Louisville, Sch Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA

[7] Yale Sch Med, Dept Pathol, New Haven, CT 06511 USA

[8] Yale Sch Med, Dept Immunobiol, New Haven, CT 06511 USA

[9] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA

[10] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA

[11] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol, St Louis, MO 63110 USA

[12] Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63110 USA

来源：

JOURNAL OF IMMUNOLOGY | 2020年 / 205卷 / 04期

基金：

美国国家卫生研究院;

关键词：

MONOCLONAL-ANTIBODIES; SPIKE PROTEIN; CORONAVIRUS; IMMUNOGLOBULIN; EXPRESSION; TOOLKIT; CLONING; COV;

D O I：

10.4049/jimmunol.2000583

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for millions of infections and hundreds of thousands of deaths globally. There are no widely available licensed therapeutics against SARS-CoV-2, highlighting an urgent need for effective interventions. The virus enters host cells through binding of a receptor-binding domain within its trimeric spike glycoprotein to human angiotensin-converting enzyme 2. In this article, we describe the generation and characterization of a panel of murine mAbs directed against the receptor-binding domain. One mAb, 2B04, neutralized wild-type SARS-CoV-2 in vitro with remarkable potency (half-maximal inhibitory concentration of <2 ng/ml). In a murine model of SARS-CoV-2 infection, 2B04 protected challenged animals from weight loss, reduced lung viral load, and blocked systemic dissemination. Thus, 2B04 is a promising candidate for an effective antiviral that can be used to prevent SARS-CoV-2 infection.

引用

页码：915 / 922

页数：8

共 50 条

[31] A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Hassan, Ahmed O.
Case, James Brett
Winkler, Emma S.
Thackray, Larissa B.
Kafai, Natasha M.
Bailey, Adam L.
McCune, Broc T.
Fox, Julie M.
Chen, Rita E.
Alsoussi, Wafaa B.
Turner, Jackson S.
Schmitz, Aaron J.
Lei, Tingting
Shrihari, Swathi
Keeler, Shamus P.
Fremont, Daved H.
Greco, Suellen
McCray, Paul B., Jr.
Perlman, Stanley
Holtzman, Michael J.
Ellebedy, Ali H.
Diamond, Michael S.
CELL, 2020, 182 (03) : 744 - +
[32] Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination
Edara, Venkata Viswanadh
Hudson, William H.
Xie, Xuping
Ahmed, Rafi
Suthar, Mehul S.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (18): : 1896 - 1898
[33] A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection
Coria, Lorena M.
Rodriguez, Juan Manuel
Demaria, Agostina
Bruno, Laura A.
Medrano, Mayra Rios
Castro, Celeste Pueblas
Castro, Eliana F.
Del Priore, Sabrina A.
Insua, Andres C. Hernando
Kaufmann, Ingrid G.
Saposnik, Lucas M.
Stone, William B.
Prado, Lineia
Notaro, Ulises S.
Amweg, Ayelen N.
Diaz, Pablo U.
Avaro, Martin
Ortega, Hugo
Ceballos, Ana
Krum, Valeria
Zurvarra, Francisco M.
Sidabra, Johanna E.
Drehe, Ignacio
Baque, Jonathan A.
Li Causi, Mariana
De Nichilo, Analia V.
Payes, Cristian J.
Southard, Teresa
Vega, Julio C.
Auguste, Albert J.
Alvarez, Diego E.
Flo, Juan M.
Pasquevich, Karina A.
Cassataro, Juliana
NATURE COMMUNICATIONS, 2024, 15 (01)
[34] A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection
Lorena M. Coria
Juan Manuel Rodriguez
Agostina Demaria
Laura A. Bruno
Mayra Rios Medrano
Celeste Pueblas Castro
Eliana F. Castro
Sabrina A. Del Priore
Andres C. Hernando Insua
Ingrid G. Kaufmann
Lucas M. Saposnik
William B. Stone
Lineia Prado
Ulises S. Notaro
Ayelen N. Amweg
Pablo U. Diaz
Martin Avaro
Hugo Ortega
Ana Ceballos
Valeria Krum
Francisco M. Zurvarra
Johanna E. Sidabra
Ignacio Drehe
Jonathan A. Baqué
Mariana Li Causi
Analia V. De Nichilo
Cristian J. Payes
Teresa Southard
Julio C. Vega
Albert J. Auguste
Diego E. Álvarez
Juan M. Flo
Karina A. Pasquevich
Juliana Cassataro
Nature Communications, 15
[35] A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection
Tai, Wanbo
Yang, Kai
Liu, Yubin
Li, Ruofan
Feng, Shengyong
Chai, Benjie
Zhuang, Xinyu
Qi, Shaolong
Shi, Huicheng
Liu, Zhida
Lei, Jiaqi
Ma, Enhao
Wang, Weixiao
Tian, Chongyu
Le, Ting
Wang, Jinyong
Chen, Yunfeng
Tian, Mingyao
Xiang, Ye
Yu, Guocan
Cheng, Gong
NATURE COMMUNICATIONS, 2023, 14 (01)
[36] A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection
Wanbo Tai
Kai Yang
Yubin Liu
Ruofan Li
Shengyong Feng
Benjie Chai
Xinyu Zhuang
Shaolong Qi
Huicheng Shi
Zhida Liu
Jiaqi Lei
Enhao Ma
Weixiao Wang
Chongyu Tian
Ting Le
Jinyong Wang
Yunfeng Chen
Mingyao Tian
Ye Xiang
Guocan Yu
Gong Cheng
Nature Communications, 14 (1)
[37] Neutralizing and enhancing antibodies against SARS-CoV-2
Liu, Yafei
Arase, Hisashi
INFLAMMATION AND REGENERATION, 2022, 42 (01)
[38] Neutralizing and enhancing antibodies against SARS-CoV-2
Yafei Liu
Hisashi Arase
Inflammation and Regeneration, 42
[39] Prospects of Neutralizing Nanobodies Against SARS-CoV-2
Chen, Fangfang
Liu, Zhihong
Jiang, Fan
FRONTIERS IN IMMUNOLOGY, 2021, 12
[40] Antibody screening at reduced pH enables preferential selection of potently neutralizing antibodies targeting SARS-CoV-2
Madan, Bharat
Reddem, Eswar R.
Wang, Pengfei
Casner, Ryan G.
Nair, Manoj S.
Huang, Yaoxing
Fahad, Ahmed S.
de Souza, Matheus Oliveira
Banach, Bailey B.
Lopez Acevedo, Sheila N.
Pan, Xiaoli
Nimrania, Rajani
Teng, I-Ting
Bahna, Fabiana
Zhou, Tongqing
Zhang, Baoshan
Yin, Michael T.
Ho, David D.
Kwong, Peter D.
Shapiro, Lawrence
DeKosky, Brandon J.
AICHE JOURNAL, 2021, 67 (12)

← 1 2 3 4 5 →